AGE

, Volume 34, Issue 5, pp 1269–1283 | Cite as

Are centenarians genetically predisposed to lower disease risk?

  • Jonatan R. Ruiz
  • Carmen Fiuza-Luces
  • Amaya Buxens
  • Amalia Cano-Nieto
  • Félix Gómez-Gallego
  • Catalina Santiago
  • Gabriel Rodríguez-Romo
  • Nuria Garatachea
  • José I. Lao
  • María Morán
  • Alejandro Lucia
Article

Abstract

Our study purpose was to compare a disease-related polygenic profile that combined a total of 62 genetic variants among (i) people reaching exceptional longevity, i.e., centenarians (n = 54, 100–108 years, 48 women) and (ii) ethnically matched healthy controls (n = 87, 19–43 years, 47 women). We computed a ‘global’ genotype score (GS) for 62 genetic variants (mutations/polymorphisms) related to cardiometabolic diseases, cancer or exceptional longevity, and also specific GS for main disease categories (cardiometabolic risk and cancer risk, including 36 and 24 genetic variations, respectively) and for exceptional longevity (7 genetic variants). The ‘global’ GS was similar among groups (centenarians: 31.0 ± 0.6; controls 32.0 ± 0.5, P = 0.263). We observed that the GS for hypertension, cancer (global risk), and other types of cancer was lower in the centenarians group compared with the control group (all P < 0.05), yet the difference became non significant after adjusting for sex. We observed significant between-group differences in the frequency of GSTT1 and GSTM1 (presence/absence) genotypes after adjusting for multiple comparisons. The likelihood of having the GSTT1 low-risk (functional) allele was higher in centenarians (odds ratio [OR] 5.005; 95% confidence interval [CI], 1.810–13.839), whereas the likelihood of having the GSTMI low-risk (functional) allele was similar in both groups (OR 1.295; 95% CI, 0.868 –1.931). In conclusion, we found preliminary evidence that Spanish centenarians have a lower genetic predisposition for cancer risk. The wild-type (i.e., functional) genotype of GSTT1, which is associated with lower cancer risk, might be associated with exceptional longevity, yet further studies with larger sample sizes must confirm these findings.

Keywords

Centenarians Genetics Exceptional longevity Ageing 

Notes

Acknowledgements

This study was supported by a grant from Fondo de Investigaciones Sanitarias (FIS, grant #PI09-00194), and by the Spanish Ministry of Science and Innovation (RYC-2010-05957).

References

  1. Abilleira S, Bevan S, Markus HS (2006) The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet 43(12):897–901PubMedCrossRefGoogle Scholar
  2. Alakus H, Monig SP, Warnecke-Eberz U, Alakus G, Winde G, Drebber U, Schmitz KJ, Schmid KW, Riemann K, Siffert W, Bollschweiler E, Holscher AH, Metzger R (2009) Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer. World J Gastroenterol 15(48):6061–6067PubMedCrossRefGoogle Scholar
  3. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272(15):10004–10012PubMedCrossRefGoogle Scholar
  4. Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crino L, Barberini F, Rulli A (2009) CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer 9:115PubMedCrossRefGoogle Scholar
  5. Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, Minelli C, Thompson J, Infante-Rivard C, Guyatt G (2009) How to use an article about genetic association: B: Are the results of the study valid? JAMA 301(2):191–197PubMedCrossRefGoogle Scholar
  6. Awad MM, Dalal D, Cho E, Amat-Alarcon N, James C, Tichnell C, Tucker A, Russell SD, Bluemke DA, Dietz HC, Calkins H, Judge DP (2006) DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet 79(1):136–142PubMedCrossRefGoogle Scholar
  7. Bagos PG, Elefsinioti AL, Nikolopoulos GK, Hamodrakas SJ (2007) The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens 25(3):487–500PubMedCrossRefGoogle Scholar
  8. Balistreri CR, Candore G, Colonna-Romano G, Lio D, Caruso M, Hoffmann E, Franceschi C, Caruso C (2004) Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292(19):2339–2340PubMedCrossRefGoogle Scholar
  9. Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H (2007) The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum Genet 121(2):169–178PubMedCrossRefGoogle Scholar
  10. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369(6475):64–67PubMedCrossRefGoogle Scholar
  11. Capoluongo E, Onder G, Concolino P, Russo A, Santonocito C, Bernabei R, Zuppi C, Ameglio F, Landi F (2009) GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study). Clin Chim Acta 399(1–2):92–96PubMedCrossRefGoogle Scholar
  12. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD (2006) Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 164(10):921–935PubMedCrossRefGoogle Scholar
  13. Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD (1995) Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333(6):352–354PubMedCrossRefGoogle Scholar
  14. Corbo RM, Ulizzi L, Positano L, Scacchi R (2011) Association of CYP19 and ESR1 pleiotropic genes with human longevity. J Gerontol A Biol Sci Med Sci 66(1):51–55PubMedCrossRefGoogle Scholar
  15. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF Jr, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS (2007) Replicating genotype-phenotype associations. Nature 447(7145):655–660PubMedCrossRefGoogle Scholar
  16. Chen B, Qiu LX, Li Y, Xu W, Wang XL, Zhao WH, Wu JQ (2010) The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects. Lung Cancer 70(3):247–252PubMedCrossRefGoogle Scholar
  17. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347(8997):295–297PubMedCrossRefGoogle Scholar
  18. Christensen K, McGue M, Petersen I, Jeune B, Vaupel JW (2008) Exceptional longevity does not result in excessive levels of disability. Proc Natl Acad Sci U S A 105(36):13274–13279PubMedCrossRefGoogle Scholar
  19. Christiansen L, Brasch-Andersen C, Bathum L, Kruse TA, Christensen K (2006) A longitudinal study of the effect of GSTT1 and GSTM1 gene copy number on survival. Mech Ageing Dev 127(7):597–599PubMedCrossRefGoogle Scholar
  20. Dallongeville J, Helbecque N, Cottel D, Amouyel P, Meirhaeghe A (2003) The Gly16→Arg16 and Gln27→Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 88(10):4862–4866PubMedCrossRefGoogle Scholar
  21. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ (2003) A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res 63(17):5236–5238PubMedGoogle Scholar
  22. Defoor J, Martens K, Zielinska D, Matthijs G, Van Nerum H, Schepers D, Fagard R, Vanhees L (2006) The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease. Eur Heart J 27(7):808–816PubMedCrossRefGoogle Scholar
  23. Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C, Hurme M, Mocchegiani E, Rea M, Lio D, Candore G, Caruso C (2009) Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev 8(1):36–42PubMedCrossRefGoogle Scholar
  24. Economopoulos KP, Choussein S, Vlahos NF, Sergentanis TN (2010) GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 20(9):1576–1580PubMedGoogle Scholar
  25. Economopoulos KP, Sergentanis TN (2010) GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer 46(9):1617–1631PubMedCrossRefGoogle Scholar
  26. Emanuele E, Fontana JM, Minoretti P, Geroldi D (2010) Preliminary evidence of a genetic association between chromosome 9p21.3 and human longevity. Rejuvenation Res 13(1):23–26PubMedCrossRefGoogle Scholar
  27. Fasching PA, Loehberg CR, Strissel PL, Lux MP, Bani MR, Schrauder M, Geiler S, Ringleff K, Oeser S, Weihbrecht S, Schulz-Wendtland R, Hartmann A, Beckmann MW, Strick R (2008) Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients. Breast Cancer Res Treat 112(1):89–98PubMedCrossRefGoogle Scholar
  28. Fiuza-Luces C, Ruiz JR, Rodriguez-Romo G, Santiago C, Gomez-Gallego F, Yvert T, Cano-Nieto A, Garatachea N, Moran M, Lucia A (2011) Are 'endurance' alleles 'survival' alleles? Insights from the ACTN3 R577X polymorphism. PLoS One 6(3):e17558PubMedCrossRefGoogle Scholar
  29. Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG, Jockel KH, Siffert W, Schmid KW (2005a) GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer. Clin Cancer Res 11(14):5071–5077PubMedCrossRefGoogle Scholar
  30. Frey UH, Eisenhardt A, Lummen G, Rubben H, Jockel KH, Schmid KW, Siffert W (2005b) The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer. Cancer Epidemiol Biomarkers Prev 14(4):871–877PubMedCrossRefGoogle Scholar
  31. Frey UH, Nuckel H, Sellmann L, Siemer D, Kuppers R, Durig J, Duhrsen U, Siffert W (2006) The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia. Clin Cancer Res 12(19):5686–5692PubMedCrossRefGoogle Scholar
  32. Friedlander Y, Schwartz SM, Durst R, Meiner V, Robertson AS, Erez G, Leitersdorf E, Siscovick DS (2008) SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction. Atherosclerosis 196(2):896–904PubMedCrossRefGoogle Scholar
  33. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Castano-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Tora M, Fernandez F, Real FX, Rothman N (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366(9486):649–659PubMedCrossRefGoogle Scholar
  34. Gomez-Gallego F, Ruiz JR, Buxens A, Altmae S, Artieda M, Santiago C, Gonzalez-Freire M, Verde Z, Arteta D, Martinez A, Tejedor D, Lao JI, Arenas J, Lucia A (2010) Are elite endurance athletes genetically predisposed to lower disease risk? Physiol Genomics 41(1):82–90PubMedCrossRefGoogle Scholar
  35. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L (2001) Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 10(3):209–216PubMedGoogle Scholar
  36. Gordi T, Khamis H (2004) Simple solution to a common statistical problem: interpreting multiple tests. Clin Ther 26(5):780–786PubMedCrossRefGoogle Scholar
  37. Hekimi S (2006) How genetic analysis tests theories of animal aging. Nat Genet 38(9):985–991PubMedCrossRefGoogle Scholar
  38. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6:65–70Google Scholar
  39. Huth C, Illig T, Herder C, Gieger C, Grallert H, Vollmert C, Rathmann W, Hamid YH, Pedersen O, Hansen T, Thorand B, Meisinger C, Doring A, Klopp N, Gohlke H, Lieb W, Hengstenberg C, Lyssenko V, Groop L, Ireland H, Stephens JW, Wernstedt Asterholm I, Jansson JO, Boeing H, Mohlig M, Stringham HM, Boehnke M, Tuomilehto J, Fernandez-Real JM, Lopez-Bermejo A, Gallart L, Vendrell J, Humphries SE, Kronenberg F, Wichmann HE, Heid IM (2009) Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant −174G>C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med 41(2):128–138PubMedCrossRefGoogle Scholar
  40. Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ (1990) Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 31(8):1337–1349PubMedGoogle Scholar
  41. Jenab M, McKay J, Bueno-de-Mesquita HB, van Duijnhoven FJ, Ferrari P, Slimani N, Jansen EH, Pischon T, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Engel P, Kaaks R, Linseisen J, Boeing H, Fisher E, Trichopoulou A, Dilis V, Oustoglou E, Berrino F, Vineis P, Mattiello A, Masala G, Tumino R, Vrieling A, van Gils CH, Peeters PH, Brustad M, Lund E, Chirlaque MD, Barricarte A, Suarez LR, Molina E, Dorronsoro M, Sala N, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Bingham S, Boffetta P, Autier P, Byrnes G, Norat T, Riboli E (2009) Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev 18(9):2485–2491PubMedCrossRefGoogle Scholar
  42. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM (1992) Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1(1):72–75PubMedCrossRefGoogle Scholar
  43. Jiang Y, Zhou L, Yan T, Shen Z, Shao Z, Lu J (2010) Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue. J Exp Clin Cancer Res 29:101PubMedCrossRefGoogle Scholar
  44. Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, Dekker JM, Hart LM, Valve R, Uusitupa MI (1998) Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 4(12):1434–1437PubMedCrossRefGoogle Scholar
  45. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, Hirschhorn JN, Berglund G, Hedblad B, Groop L, Altshuler DM, Newton-Cheh C, Orho-Melander M (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358(12):1240–1249PubMedCrossRefGoogle Scholar
  46. Kolovou G, Stamatelatou M, Anagnostopoulou K, Kostakou P, Kolovou V, Mihas C, Vasiliadis I, Diakoumakou O, Mikhailidis DP, Cokkinos DV (2010) Cholesteryl ester transfer protein gene polymorphisms and longevity syndrome. Open Cardiovasc Med J 4:14–19PubMedCrossRefGoogle Scholar
  47. Kucharska-Newton AM, Monda KL, Campbell S, Bradshaw PT, Wagenknecht LE, Boerwinkle E, Wasserman BA, Heiss G (2011) Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 216(1):151–156PubMedCrossRefGoogle Scholar
  48. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 338(2):86–93PubMedCrossRefGoogle Scholar
  49. Lanz JR, Pereira AC, Lemos PA, Martinez E, Krieger JE (2005) Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta 362(1–2):176–181PubMedCrossRefGoogle Scholar
  50. Lehnerdt GF, Franz P, Winterhoff S, Bankfalvi A, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH (2008) The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope 118(12):2172–2176PubMedCrossRefGoogle Scholar
  51. Lescai F, Marchegiani F, Franceschi C (2009) PON1 is a longevity gene: results of a meta-analysis. Ageing Res Rev 8(4):277–284PubMedCrossRefGoogle Scholar
  52. Liao C, Cao Y, Wu L, Huang J, Gao F (2009) An updating meta-analysis of the glutathione S-transferase T1 polymorphisms and colorectal cancer risk: a HuGE review. Int J Colorectal DisGoogle Scholar
  53. Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, Hoffmann E, Caruso M, Licastro F, Caldarera CM, Branzi A, Franceschi C, Caruso C (2004) Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 41(10):790–794PubMedCrossRefGoogle Scholar
  54. Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC (2004) The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer 101(12):2802–2808PubMedCrossRefGoogle Scholar
  55. Margaglione M, Brancaccio V, Ciampa A, Papa ML, Grandone E, Di Minno G (2001) Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings. Haematologica 86(6):634–639PubMedGoogle Scholar
  56. Margaglione M, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, Grandone E, Pennelli O, Di Minno G (1998) The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol 18(2):152–156PubMedCrossRefGoogle Scholar
  57. Martin GM, Bergman A, Barzilai N (2007) Genetic determinants of human health span and life span: progress and new opportunities. PLoS Genet 3(7):e125PubMedCrossRefGoogle Scholar
  58. McGrath M, Hankinson SE, Arbeitman L, Colditz GA, Hunter DJ, De Vivo I (2004) Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. Carcinogenesis 25(4):559–565PubMedCrossRefGoogle Scholar
  59. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A (2001) Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10(6):635–640PubMedGoogle Scholar
  60. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786–>C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99(22):2864–2870PubMedCrossRefGoogle Scholar
  61. Niu W, Qi Y (2010) Association of the angiotensin II type I receptor gene +1166 A>C polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects. Hypertens Res 33(11):1137–1143PubMedCrossRefGoogle Scholar
  62. Onder G, Capoluongo E, Giovannini S, Concolino P, Russo A, Liperoti R, Bernabei R, Landi F (2011) Interaction between GSTM1 genotype and IL-6 on mortality in older adults: results from the ilSIRENTE study. Cytokine 53(3):301–305PubMedCrossRefGoogle Scholar
  63. Pesch B, Dusing R, Rabstein S, Harth V, Grentrup D, Bruning T, Landt O, Vetter H, Ko YD (2004) Polymorphic metabolic susceptibility genes and longevity: a study in octogenarians. Toxicol Lett 151(1):283–290PubMedCrossRefGoogle Scholar
  64. Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP (1995) Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 95(3):1225–1234PubMedCrossRefGoogle Scholar
  65. Rall SC Jr, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP (1989) Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. J Clin Invest 83(4):1095–1101PubMedCrossRefGoogle Scholar
  66. Risch HA, Bale AE, Beck PA, Zheng W (2006) PGR +331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 15(9):1738–1741PubMedCrossRefGoogle Scholar
  67. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G Jr, Grubb R 3rd, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF Jr, Silverman DT, Chanock SJ (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42(11):978–984PubMedCrossRefGoogle Scholar
  68. Ruano G, Seip RL, Windemuth A, Zollner S, Tsongalis GJ, Ordovas J, Otvos J, Bilbie C, Miles M, Zoeller R, Visich P, Gordon P, Angelopoulos TJ, Pescatello L, Moyna N, Thompson PD (2006) Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis 185(1):65–69PubMedCrossRefGoogle Scholar
  69. Ruiz JR, Arteta D, Buxens A, Artieda M, Gomez-Gallego F, Santiago C, Yvert T, Moran M, Lucia A (2010) Can we identify a power-oriented polygenic profile? J Appl Physiol 108(3):561–566PubMedCrossRefGoogle Scholar
  70. Ruiz JR, Gomez-Gallego F, Santiago C, Gonzalez-Freire M, Verde Z, Foster C, Lucia A (2009) Is there an optimum endurance polygenic profile? J Physiol 587(Pt 7):1527–1534PubMedCrossRefGoogle Scholar
  71. Sadaf A, Siddiqui S, Lestringant GG, Frossard PM (2002) Apolipoprotein AI promoter variant in blood pressure determination. Clin Genet 61(4):314–316PubMedCrossRefGoogle Scholar
  72. Salvioli S, Capri M, Santoro A, Raule N, Sevini F, Lukas S, Lanzarini C, Monti D, Passarino G, Rose G, De Benedictis G, Franceschi C (2008) The impact of mitochondrial DNA on human lifespan: a view from studies on centenarians. Biotechnol J 3(6):740–749PubMedCrossRefGoogle Scholar
  73. Sancho J, Re R, Burton J, Barger AC, Haber E (1976) The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation 53(3):400–405PubMedCrossRefGoogle Scholar
  74. Santovito A, Cervella P, Burgarello C, Bigatti MP, Sella G, Delpero M (2008) Analysis of glutathione S-transferase M1 and glutathione S-transferase T1 gene polymorphisms suggests age-related relationships in a northern Italian population. Arch Toxicol 82(12):903–907PubMedCrossRefGoogle Scholar
  75. Satra M, Samara M, Wosniak G, Tzavara C, Kontos A, Valotassiou V, Vamvakopoulos NK, Tsougos I, Aleporou-Marinou V, Patrinos GP, Kollia P, Georgoulias P (2011) Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion. Pharmacogenomics 12(2):195–203PubMedCrossRefGoogle Scholar
  76. Sergentanis TN, Economopoulos KP (2010) GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121(1):195–202PubMedCrossRefGoogle Scholar
  77. Siegerink B, Rosendaal FR, Algra A (2009) Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost 7(3):385–390PubMedCrossRefGoogle Scholar
  78. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B (1998) Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18(1):45–48PubMedCrossRefGoogle Scholar
  79. Slowik A, Dziedzic T, Pera J, Wloch D, Kopec G, Szczudlik A (2007) ACE genotype, risk and causal relationship to stroke: implications for treatment. Curr Treat Options Cardiovasc Med 9(3):198–204PubMedCrossRefGoogle Scholar
  80. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, Gao C, Li Z, Wang J, Takezaki T, Tajima K, Varga T, Sawaguchi T, Lum JK, Martinson JJ, Tsugane S, Iwamasa T, Shinmura K, Yokota J (1999) hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 8(8):669–674PubMedGoogle Scholar
  81. Tejedor D, Castillo S, Mozas P, Jimenez E, Lopez M, Tejedor MT, Artieda M, Alonso R, Mata P, Simon L, Martinez A, Pocovi M (2005) Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 51(7):1137–1144PubMedCrossRefGoogle Scholar
  82. Terry DF, Sebastiani P, Andersen SL, Perls TT (2008) Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med 168(3):277–283PubMedCrossRefGoogle Scholar
  83. Tsai MY, Li N, Sharrett AR, Shea S, Jacobs DR Jr, Tracy R, Arnett D, Arends V, Post W (2009) Associations of genetic variants in ATP-binding cassette A1 and cholesteryl ester transfer protein and differences in lipoprotein subclasses in the multi-ethnic study of atherosclerosis. Clin Chem 55(3):481–488PubMedCrossRefGoogle Scholar
  84. Ukkola O, Kesaniemi YA (2007) Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects. Eur J Clin Nutr 61(9):1102–1105PubMedCrossRefGoogle Scholar
  85. Utermann G (1987) Apolipoprotein E polymorphism in health and disease. Am Heart J 113(2 Pt 2):433–440PubMedCrossRefGoogle Scholar
  86. Varga EA, Sturm AC, Misita CP, Moll S (2005) Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 111(19):e289–e293PubMedCrossRefGoogle Scholar
  87. Verde Z, Ruiz JR, Santiago C, Valle B, Bandres F, Calvo E, Lucia A, Gomez Gallego F (2010) A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants. PLoS One 5(6):e11210PubMedCrossRefGoogle Scholar
  88. Wagoner LE, Craft LL, Zengel P, McGuire N, Rathz DA, Dorn GW 2nd, Liggett SB (2002) Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 144(5):840–846PubMedGoogle Scholar
  89. Wang C, Tao W, Chen Q, Hu H, Wen XY, Han R (2010) SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis. Prostate 70(2):170–178PubMedGoogle Scholar
  90. Wang Y, Spitz MR, Schabath MB, Ali-Osman F, Mata H, Wu X (2003) Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer 40(1):25–32PubMedCrossRefGoogle Scholar
  91. Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, Zhu A, Ryan DP, Christiani DC, Liu G (2008) Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer 112(5):1037–1042PubMedCrossRefGoogle Scholar
  92. Zhou JB, Yang JK, Lu JK, An YH (2009) Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis. Mol Biol RepGoogle Scholar
  93. Zhuo X, Cai L, Xiang Z, Li Q, Zhang X (2009) GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res 28:46PubMedCrossRefGoogle Scholar
  94. Zintzaras E, Raman G, Kitsios G, Lau J (2008) Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 168(10):1077–1089PubMedCrossRefGoogle Scholar

Copyright information

© American Aging Association 2011

Authors and Affiliations

  • Jonatan R. Ruiz
    • 1
    • 2
  • Carmen Fiuza-Luces
    • 3
  • Amaya Buxens
    • 4
  • Amalia Cano-Nieto
    • 5
  • Félix Gómez-Gallego
    • 3
  • Catalina Santiago
    • 3
  • Gabriel Rodríguez-Romo
    • 6
  • Nuria Garatachea
    • 7
  • José I. Lao
    • 8
  • María Morán
    • 9
  • Alejandro Lucia
    • 3
  1. 1.Department of Physical Education and Sport, School of Physical Activity and Sport SciencesUniversity of GranadaGranadaSpain
  2. 2.Department of Biosciences and Nutrition at NOVUM, Unit for Preventive NutritionKarolinska InstitutetStockholmSweden
  3. 3.Universidad Europea de MadridMadridSpain
  4. 4.Progenika Biopharma, Parque Tecnológico de ZamudioDerioSpain
  5. 5.SUAP Archena, Hospital Morales MeseguerMurciaSpain
  6. 6.INEF, Universidad Politécnica de MadridMadridSpain
  7. 7.Faculty of Health and Sport Science Department of Physiotherapy and NursingUniversity of ZaragozaZaragozaSpain
  8. 8.Preventia-GeneticsDerioSpain
  9. 9.Centro de Investigación Hospital 12 de Octubre and CIBERERMadridSpain

Personalised recommendations